- Home
- GPCR vs BHE Comparison
GPCR vs BHE Comparison
Compare GPCR & BHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- BHE
- Stock Information
- Founded
- GPCR 2016
- BHE 1979
- Country
- GPCR United States
- BHE United States
- Employees
- GPCR N/A
- BHE N/A
- Industry
- GPCR
- BHE Electrical Products
- Sector
- GPCR
- BHE Technology
- Exchange
- GPCR Nasdaq
- BHE Nasdaq
- Market Cap
- GPCR 1.8B
- BHE 1.7B
- IPO Year
- GPCR 2023
- BHE 1990
- Fundamental
- Price
- GPCR $34.17
- BHE $47.06
- Analyst Decision
- GPCR Buy
- BHE Strong Buy
- Analyst Count
- GPCR 5
- BHE 3
- Target Price
- GPCR $86.80
- BHE $42.33
- AVG Volume (30 Days)
- GPCR 677.5K
- BHE 272.0K
- Earning Date
- GPCR 11-13-2024
- BHE 10-30-2024
- Dividend Yield
- GPCR N/A
- BHE 1.45%
- EPS Growth
- GPCR N/A
- BHE N/A
- EPS
- GPCR N/A
- BHE 1.72
- Revenue
- GPCR N/A
- BHE $2,690,572,000.00
- Revenue This Year
- GPCR N/A
- BHE N/A
- Revenue Next Year
- GPCR N/A
- BHE $4.51
- P/E Ratio
- GPCR N/A
- BHE $27.37
- Revenue Growth
- GPCR N/A
- BHE N/A
- 52 Week Low
- GPCR $26.61
- BHE $24.75
- 52 Week High
- GPCR $66.38
- BHE $52.57
- Technical
- Relative Strength Index (RSI)
- GPCR 35.81
- BHE 51.59
- Support Level
- GPCR $33.85
- BHE $50.81
- Resistance Level
- GPCR $38.48
- BHE $52.57
- Average True Range (ATR)
- GPCR 2.62
- BHE 1.75
- MACD
- GPCR -0.36
- BHE -0.04
- Stochastic Oscillator
- GPCR 3.67
- BHE 45.61
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
About BHE Benchmark Electronics Inc.
Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and advanced manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.